An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

Published:2004-11 Issue:11 Volume:91 Page:1873-1879
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Hus I, ,Dmoszynska A,Manko J,Hus M,Jawniak D,Soroka-Wojtaszko M,Hellmann A,Ciepluch H,Skotnicki A,Wolska-Smolen T,Sulek K,Robak T,Konopka L,Kloczko J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602225.pdf

Reference37 articles.

1. Anagnostopoulos A, Weber D, Rankin K, Delasalle K, Alexamnn R (2003) Thalidomide and dexamethasone for resistant multiple myeloma. Br J Haematolo 121: 768–771

2. Ahmad I, Islam T, Chanan -Khan A, Hahn T, Wentling D, Becker JL, McCarthy Jr PL, Alam AR (2002) Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologousPBSCT. Bone Marrow Transplant 27: 577–580

3. Barlogie B, Desikan R, Eddlemon P, Spencer T, Zeldis J, Munshi N, Badros A, Zangari M, Anaissie E, Epstein J, Shaughnessy J, Ayers D, Spoon D, Tricot G (2001a) Extended survival in advanced andrefractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in aphase 2 study of 169 patients. Blood 98: 492–494

4. Barlogie B, Tricot G, Anaissie E (2001b) Thalidomide in the management of multiple myeloma. Semin Oncol 28: 577–582

5. Cavenagh JD, Oakervee H (2003) Thalidomide in multiple myeloma- current status and future prospects. Br J Haematol 120: 18–26

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dziesięciolecie Polskiej Grupy Szpiczakowej – historia i osiągnięcia;Acta Haematologica Polonica;2015-05

2. Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma;Haematologica;2014-09-26

3. Leki immunomodulujące – przełom w leczeniu nowotworów hematologicznych;Acta Haematologica Polonica;2013-10

4. Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation;Journal of Clinical Oncology;2012-07-10

5. A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma;The Korean Journal of Internal Medicine;2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3